Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice

Autoimmunity Reviews

Volumn 12, Issue 12, 2013, Pages 1118-1122

  Noel, Nicolas ^a,e   André, Chantal ^a,b   Bengoufa, Djaouida ^a   Dehoulle, Catherine ^a   Mahler, Michael ^d   Limal, Nicolas ^a   Godeau, Bertrand ^a,b   Hüe, Sophie ^a,b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c INSERM U955   (France)

^d INOVA DIAGNOSTICS INC   (United States)

^e BICÊTRE HOSPITAL   (France)

Author keywords

ANCA; Detection methods; Granulomatosis with Polyangiitis; PR3

Indexed keywords

MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; RECOMBINANT PROTEIN;

ADULT; AGED; ANTIBODY TITER; AREA UNDER THE CURVE; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; GRANULOMATOSIS; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOLOGY TEST KIT; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY;

ANCA; DETECTION METHODS; GRANULOMATOSIS WITH POLYANGIITIS; PR3;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUMINESCENT MEASUREMENTS; MIDDLE AGED; MYELOBLASTIN; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 84884702083     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.06.009     Document Type: Review

References (22)

1. Radice A., Bianchi L., Sinico R.A. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev 2013, 12(4):487-495.
2. Holle J.U., Gross W.L. Treatment of ANCA-associated vasculitides (AAV). Autoimmun Rev 2013, 12(4):483-486.
3. Savige J., Gillis D., Benson E., Davies D., Esnault V., Falk R.J., et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999, 111(4):507-513.
4. Lochman I., Král V., Lochmanová A., Lupač J., Cebecauer L. ANCA in the diagnosis of neutrophil-mediated inflammation. Autoimmun Rev 2011, 10(6):295-298.
5. Csernok E., Ahlquist D., Ullrich S., Gross W.L. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology (Oxford) 2002, 41(11):1313-1317.
6. Csernok E., Holle J., Hellmich B., Willem J., Tervaert C., Kallenberg C.G.M., et al. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology (Oxford) 2004, 43(2):174-180.
7. Damoiseaux J., Dähnrich C., Rosemann A., Probst C., Komorowski L., Stegeman C.A., et al. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis 2009, 68(2):228-233.
8. Damoiseaux J., Vaessen M., Knapen Y., Csernok E., Stegeman C.A., Van Paassen P., et al. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease. Ann N Y Acad Sci 2007, 1109:454-463.
9. Hellmich B., Csernok E., Fredenhagen G., Gross W.L. A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. Clin Exp Rheumatol 2007, 25(1 Suppl. 44):S1-S5.
10. Mahler M., Radice A., Yang W., Bentow C., Seaman A., Bianchi L., et al. Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. Clin Chim Acta 2012, 413(7-8):719-726.
11. Rarok A.A., Huitema M.G., Van der Leij M.J., Van der Geld Y.M., Berthold H., Schmitt J., et al. Recombinant protein to analyze autoantibodies to proteinase 3 in systemic vasculitis. Am J Clin Pathol 2003, 120(4):586-595.
12. Kaul R., Johnson K., Scholz H., Marr G. Performance of the BioPlex 2200 Autoimmune Vasculitis kit. Autoimmun Rev 2009, 8(3):224-227.
13. Holle J.U., Hellmich B., Backes M., Gross W.L., Csernok E. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?. Ann Rheum Dis 2005, 64(12):1773-1779.
14. Holle J.U., Herrmann K., Gross W.L., Csernok E. Comparative analysis of different commercial ELISA systems for the detection of anti-neutrophil cytoplasm antibodies in ANCA-associated vasculitides. Clin Exp Rheumatol 2012, 30(1 Suppl. 70):S66-69.
15. Segelmark M., Phillips B.D., Hogan S.L., Falk R.J., Jennette J.C. Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis. Clin Diagn Lab Immunol 2003, 10(5):769-774.
16. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37(2):187-192.
17. Jennette J., Falk R., Bacon P., Basu N., Cid M., Ferrario F., et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65(1):1-11.
18. Mahr A.D., Neogi T., Lavalley M.P., Davis J.C., Hoffman G.S., McCune W.J., et al. Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. Arthritis Rheum 2008, 59(6):884-891.
19. Roggenbuck D., Buettner T., Hoffmann L., Schmechta H., Reinhold D., Conrad K. High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay. Ann N Y Acad Sci 2009, 1173:41-46.
20. Trevisin M., Pollock W., Dimech W., Savige J. Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD). J Immunol Methods 2008, 336(2):104-112.
21. Radice A., Vecchi M., Bianchi M.B., Sinico R.A. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin Exp Rheumatol 2000, 18(6):707-712.
22. Trevisin M., Pollock W., Dimech W., Melny J., Paspaliaris B., Gillis D., et al. Antigen-specific ANCA ELISAs have different sensitivities for active and treated vasculitis and for nonvasculitic disease. Am J Clin Pathol 2008, 129(1):42-53.